📰 Genentech News
Page 87 - Genentech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genentech. Real-time updates on events, politics, business and more.
October 23, 2023
MAINZ, Germany, October 23, 2023 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the...
October 23, 2023
New AREF-Roche and Genentech Fellowship Program set to support emerging African scientists to become leaders in their fields.
October 23, 2023
A new 137-foot, eight-story life science building is moving forward in the heart of the city’s Bayfront area, as the South San Francisco Planning Commission approved the project’s California Environmental
October 23, 2023
The fast pace of information can make it difficult to efficiently apply data to care.
October 23, 2023
BNT211 combines two innovative approaches in one regimen with first-in-class potential: an autologous CAR-T cell therapy targeting the oncofetal antigen Claudin-6 (CLDN6) and a CLDN6-encoding CAR-T cell amplifying RNA
October 23, 2023
SYDNEY, Oct. 23, 2023 /PRNewswire/ -- Kazia Therapeutics Limited , an oncology-focused drug development company, announces that selected clinical data from the companys ongoing Phase 1 clinical...
October 23, 2023
Health news and commentary from around the Web gathered by <em>MedPage Today</em> staff
October 23, 2023
BNT211 combines two innovative approaches in one regimen with first-in-class potential: an autologous CAR-T cell therapy targeting the oncofetal antigen Claudin-6 and a CLDN6-encoding CAR-T cell...
October 23, 2023
This and other insights from one woman living with this chronic neurological disorder.
October 23, 2023
Swiss pharmaceutical company Roche has settled a patent lawsuit against U.S. biotech firm Biogen over its biosimilar version of Roches blockbuster rheumatoid arthritis drug Actemra, according to...